Securus Technologies is a name to reckon with in the field of prison communication and technology solutions and serves more than 3,450 law enforcement, police, and public safety agencies. The services of the company reach out to over 120,000 inmates across the United States. The primary aim of the group is to help prisoners communicate in a contemporary manner and help sync their prison life with the happenings of the outside world and stay in touch with their friends and family.
In the 11th Stevie Awards, one of the most prestigious corporate awards in the country held annually, Securus Technologies was nominated a finalist in the category of the customer service training department. The management at Securus Technologies is profoundly hopeful and excited about this development and are keeping their fingers crossed. As the participants for the awards can be from across the globe and this year, over 2,300 applications were filed, it is a matter of jubilation for the company to be named a finalist. Even if the company does not secure the Gold Awards, being a finalist means they would at least walk away with the Bronze award.
Stevie Awards is one of the most prestigious names in the corporate sector and organizes a total of seven premier business award shows each year. It includes the famous international trade awards as well as the Stevie Awards for great employers. The award presentation would be held at the famous Caesars Palace Hotel in Las Vegas. Securus Technologies serves over a million clients and has a diverse range of products and services to offer. Each year the company launches a stream of new products and services, and last year they inaugurated the video visitation service for its clientele. Securus Technologies are happy to be nominated for the Gold Stevie Awards, and the management believes they would be named the winner.
Eric Lefkofsky is the co-founder of Tempus, a technological company that was founded to fight against cancer. Tempus is in the process of building an extensive database of molecular data, that will give doctors the latest information to treat cancer. With this amazing technology, Tempus hopes to improve cancer treatment worldwide.
The University of Chicago and Tempus have joined to help treat breast cancer patients. Tempus will study over 1,000 breast cancer patients and attempt to find molecular patterns that can assist doctors in treating each patient. Breast cancer affects over 250,000 women each year in the United States, and there is little data on the patients that have been diagnosed with this disease. Eventually, Tempus hopes to improve cancer treatment and increase the life expectancy for anyone afflicted with this terrible condition. Tempus has also joined other universities and clinics to help uncover molecular data for various cancers. These studies are an excellent foundation for doctors to learn how cancer uniquely affects each patient. Under the guidance of Eric Lefkofsky, Tempus will be a great asset for the researchers at the University of Chicago and other educational institutions.
Besides co-founding Tempus, Eric Lefkofsky has been a highly successful businessman that has founded many successful companies. He began his career in 1999, co-founding Starbelly, an internet company that sold promotional products. Lefkofsky eventually co-funded other companies; including InnerWorkings, Echo Global Logistics, and MediaBank. He was also the founder of Groupon, an e-commerce company based in Chicago that provides great deals for cities across the globe. He eventually stepped down as CEO in 2015, but he remains with the company as a chairman. Eric Lefkofsky has also donated to many charities and universities across the United States. The Lefkofsky Family Foundation was created in 2006 and gives to a variety of organizations, including healthcare, medical research, and education. The generosity and brilliance of Eric Lefkofsky will continue to make the world a much better place.
Clay Siegall is the co-founder of Seattle Genetics which was established in 1998. He is the company’s chief executive officer, president and the chairman to the board. He is a scientist by training and concentrates on cancer therapies. His passion for helping patients led him to establish Seattle Genetics through drug development practices, scientific innovation and vast research. Under his leadership the company has made a name for itself in the development of cancer drugs. First, the company has come up with antibody-drug conjugates and acquired approval in 2011 for the sale of the first product. Seattle Genetics is advancing a wide pipeline of proprietary business that can supply the antibody-drug conjugates that will be channeled towards treatment of cancer.
Due to the aggressive nature of Siegall Genetics has acquired multiple licenses aimed at facilitating the antibody drug conjugated technology. Such licenses include those with prominent organizations such as GlaxoSmithKline and Genentech. In addition to the above, there are more than twenty Anti-body conjugates clinical developments using Seattle technology. Moreover, Dr. Siegall has also participated in finance raising activities of the organization both from the private and public sector. He took part in the initial public offer that was conducted in the year 2001. Due to his good work and his expertise in science he has won a few awards which are; 2013 University of Maryland alumnus of the year award and 2012 Pacific Northwest Ernst and Young entrepreneur of the year.
“Genes that preserve health; genes that block cancer development” is one of the most recent articles by Clay Siegall. It talks about the discovery of the modifier genes that can fight cancer. It prevents cancer by blocking inflammations therefore preventing colon cancer despite exposure to foods that cause cancer. The article clearly demonstrated how the modifier genes could be used appropriately to prevent the disease. The other article is about FenoLogica Biosciences signing licensing and collaboration agreements with Pacific North West Research Institute giving scientist access to the research institute. The avenue created will help scientist research on the causes of diseases and treatment available for the same. It will make the work easier through the high technology and insights that come with the agreements.
EOS lip balm has done amazing things in the short seven years the brand has been around. First, they used their own money to start the business, and used their aggressive and smart marketing strategies on Facebook and social media to get their lip balm on the shelves at Walgreens. They were confident in their product, and knew that getting it out there would be all that it’d take to create uproar. And that they did.
EOS is now a brand purchased more than Chapstick or Blistex, two of the leading lip balm brands for many years now. No one ever imagined that it could be done, but the creators of EOS were out to accomplish this feat. Now, they can rest easy as they’ve done it, and fairly quickly per most standards.
EOS lip balm is different from the other products on the market today, although many companies have introduced their own copycat version of the EOS product since 2009. EOS uses all-natural ingredients in their lip balms, ensuring no irritation or problems later down the road. The product focuses on a woman’s five senses, helping her feel alive each time she reaches for her Orb. The EOS lip balm keeps lips soft and smooth, and is reasonably priced on eBay.
Chapstick maintained a ‘if it isn’t broke, don’t fix it’ attitude, and they’re now paying for the assumption that customers were pleased with the options available. EOS provided women with a trendy, fun product that worked wonderfully, and the results have paid off generously.
Chris Burch is one of the most prominent business entities in the United States. As a matter of fact, he has worked to found and sell companies from scratch. For all his years of experience, he is determined to found better working capabilities in a manner that is anticipated in this industry. For this reason, Chris Burch is recognized in this industry as a prominent serial entrepreneur. Because of his many years of experience, he has developed a way for a person to determine the better business capability. As a matter of fact, he would found a better business to become a business entity in the United States.
Chris Burch has also determined that the technology industry has many similarities with the fashion industry. As a matter of fact, the two industries have developed in a manner that is not paralleled in the industry. The fashion industry is one of the most prosperous business entities. For fashion to develop high-end capabilities, it must become renovated in a manner that shows the relocation in this era. According to Chris Burch, the fashion industry borrows many things from, the technology industry. On the other hand, technology has a lot to do with fashion. As a matter of fact, technology won’t be popular if fashion was not associated with the equation.
For technology to develop to become popular, it must be adopted on a massive scale among the people. For this reason, this adoption is as a result of fashion. It must become fashionable among the people to get better market demand and popularity. A fascinating part of the story is how the two industries have grown together. For this reason, we end up working for capabilities that never simulate market stability. Fashion, on the other hand, must contain technology for the people to adopt its use on a massive scale. For this reason, technology and fashion have a thin line separating them, while they appear to have many differences, they will always grow together in a manner that is unparalleled in the industry. For this reason, people need to understand that technology is always on the winning end.
We might also ask ourselves how the two industries have grown together. This is the fascinating part of the story. When we look at the past events, all our questions will be answered. The 70s brought about the boom box technology that was considered as fashionable. If it weren’t fashionable, it wouldn’t be taken as an entity.
Read more about Chris Burch: